Biochemical and Sociodemographic Correlates of Major Depressive Disorder in Patients With Chronic Kidney Disease Receiving Hemodialysis

被引:1
|
作者
Kumar, Ashutosh [1 ]
Jain, Apoorva [2 ]
Rikhari, Praveen [1 ]
机构
[1] Sarojini Naidu Med Coll, Psychiat, Agra, Uttar Pradesh, India
[2] Sarojini Naidu Med Coll, Nephrol, Agra, Uttar Pradesh, India
关键词
ham-d; mdd; hemodialysis; depression; ckd; STAGE RENAL-DISEASE; PREVALENCE; DIALYSIS; ANXIETY; ASSOCIATION; MANAGEMENT; MORTALITY; SYMPTOMS;
D O I
10.7759/cureus.43267
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Chronic kidney disease (CKD) is a chronic disabling illness with multiple physical and psychosocial consequences. A major treatment modality for CKD is renal replacement therapy in the form of hemodialysis. A bidirectional relationship between depression and CKD is proposed, as depressive symptoms lead to poorer outcomes in CKD and vice versa. This study aimed to determine the prevalence of major depressive disorder (MDD) in CKD patients on maintenance hemodialysis and find any sociodemographic, clinical, or biochemical correlates. Material and methods This was a cross-sectional study conducted at a tertiary care teaching hospital in north India. We used clinical interviews for diagnosing MDD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). The severity was quantified using Hamilton Depression Rating Scale (HAM-D) in those diagnosed with MDD. Results A total of 77 patients were included in the study. The prevalence of MDD in patients with CKD undergoing hemodialysis was 31.17%, much higher than in the general population. Most of those who were depressed had moderate to severe depression. Male gender and lower socioeconomic status were significantly associated with the diagnosis of MDD. Those undergoing dialysis less frequently or having more work days lost due to CKD were more likely to be depressed. Additionally, patients with MDD were found to have significantly lower blood hemoglobin levels, lower serum ionized calcium levels, and a lower urea reduction ratio compared to those who did not have MDD. Conclusion The high prevalence of MDD in patients with CKD undergoing hemodialysis suggests that clinicians should actively evaluate for depressive symptoms in this patient population and refer them to mental health services when required, especially those with the above-identified sociodemographic and biochemical risk factors.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Efficacy and tolerability of Escitalopram in patients with chronic kidney disease undergoing hemodialysis having depressive disorder
    Naik, Bhavyashree Laxman
    Babu, Girish N.
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
  • [2] Nutritional status in patients with chronic kidney disease receiving hemodialysis
    Welland, Natasha
    Sele, Kristin
    Marti, Hans-Peter
    Dierkes, Jutta
    ANNALS OF NUTRITION AND METABOLISM, 2015, 67 : 464 - 464
  • [3] Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
    Lim, Ah-Young
    Lee, Ah-Rong
    Hatim, Ahmad
    Tian-Mei, Si
    Liu, Chia-Yih
    Jeon, Hong Jin
    Udomratn, Pichet
    Bautista, Dianne
    Chan, Edwin
    Liu, Shen-Ing
    Chua, Hong Choon
    Hong, Jin Pyo
    BMC PSYCHIATRY, 2014, 14
  • [4] Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
    Ah-Young Lim
    Ah-Rong Lee
    Ahmad Hatim
    Si Tian-Mei
    Chia-Yih Liu
    Hong Jin Jeon
    Pichet Udomratn
    Dianne Bautista
    Edwin Chan
    Shen-Ing Liu
    Hong Choon Chua
    Jin Pyo Hong
    BMC Psychiatry, 14
  • [5] Major depressive disorder in hemodialysis patients in China
    Hu, Aimin
    Xue, Zhimin
    Mwansisya, Tumbwene E.
    Zhou, An
    Pu, Weidan
    Chen, Xudong
    Sun, Meng
    Wang, Peng
    Fan, Hua
    Wang, Zheng
    Ouyang, Xuan
    Liu, Zhening
    Rosenheck, Robert
    ASIA-PACIFIC PSYCHIATRY, 2015, 7 (01) : 78 - 84
  • [6] Evaluation of Major Depressive Disorder in Patients Receiving Chronic Treatment with Topical Timolol
    Bali, Shveta Jindal
    Parmar, Twinkle
    Arora, Vishal
    Ichhpujani, Parul
    Sagar, Rajesh
    Dada, Tanuj
    OPHTHALMOLOGICA, 2011, 226 (03) : 157 - 160
  • [7] Biochemical Assessment In Patients With Major Depressive Disorder
    Puria, Alka
    Goyal, Ekram
    Singh, Sude Kumar
    Saldanha, D.
    INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S50 - S50
  • [8] Telavancin pharmacokinetics in patients with chronic kidney disease receiving hemodialysis.
    Gharibian, Katherine N.
    Lewis, Susan J.
    Heung, Michael
    Segal, Jonathan H.
    Salama, Noha N.
    Mueller, Bruce A.
    PHARMACOTHERAPY, 2016, 36 (12): : E256 - E256
  • [9] Electrophysiological correlates of mindfulness in patients with major depressive disorder
    Sarlon, Jan
    Bruehl, Annette B.
    Lang, Undine E.
    Kordon, Andreas
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [10] Correlates of Disability in Asian Patients With Major Depressive Disorder
    Eurviriyanukul, Kanokkwan
    Srisurapanont, Manit
    Udomratn, Pichet
    Sulaiman, Ahmad Hatim
    Liu, Chia-Yih
    PERSPECTIVES IN PSYCHIATRIC CARE, 2016, 52 (04) : 265 - 272